Suppr超能文献

CD8 + T细胞衍生的可溶性因子可抑制单核细胞/巨噬细胞中的HIV-1复制,而β趋化因子RANTES、MIP-1α和MIP-1β则不能。

CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages.

作者信息

Moriuchi H, Moriuchi M, Combadiere C, Murphy P M, Fauci A S

机构信息

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15341-5. doi: 10.1073/pnas.93.26.15341.

Abstract

It has been demonstrated that CD8+ T cells produce a soluble factor(s) that suppresses human immuno-deficiency virus (HIV) replication in CD4+ T cells. The role of soluble factors in the suppression of HIV replication in monocyte/macrophages (M/M) has not been fully delineated. To investigate whether a CD8+ T-cell-derived soluble factor(s) can also suppress HIV infection in the M/M system, primary macrophages were infected with the macrophage tropic HIV-1 strain Ba-L. CD8+ T-cell-depleted peripheral blood mononuclear cells were also infected with HIV-1 IIIB or Ba-L. HIV expression from the chronically infected macrophage cell line U1 was also determined in the presence of CD8+ T-cell supernatants or beta-chemokines. We demonstrate that: (i) CD8+ T-cell supernatants did, but beta-chemokines did not, suppress HIV replication in the M/M system; (ii) antibodies to regulated on activation normal T-cell expressed and Secreted (RANTES), macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta did not, whereas antibodies to interleukin 10, interleukin 13, interferon alpha, or interferon gamma modestly reduced anti-HIV activity of the CD8+ T-cell supernatants; and (iii) the CD8+ T-cell supernatants did, but beta-chemokines did not, suppress HIV-1 IIIB replication in peripheral blood mononuclear cells as well as HIV expression in U1 cells. These results suggest that HIV-suppressor activity of CD8+ T cells is a multifactorial phenomenon, and that RANTES, MIP-1 alpha, and MIP-1 beta do not account for the entire scope of CD8+ T-cell-derived HIV-suppressor factors.

摘要

已证明CD8 + T细胞产生一种可溶性因子,可抑制人类免疫缺陷病毒(HIV)在CD4 + T细胞中的复制。可溶性因子在抑制单核细胞/巨噬细胞(M/M)中HIV复制的作用尚未完全阐明。为了研究CD8 + T细胞衍生的可溶性因子是否也能抑制M/M系统中的HIV感染,将原代巨噬细胞用嗜巨噬细胞性HIV-1毒株Ba-L感染。去除CD8 + T细胞的外周血单核细胞也用HIV-1 IIIB或Ba-L感染。在存在CD8 + T细胞上清液或β趋化因子的情况下,还测定了慢性感染的巨噬细胞系U1中的HIV表达。我们证明:(i)CD8 + T细胞上清液可抑制M/M系统中的HIV复制,而β趋化因子则不能;(ii)针对激活正常T细胞表达和分泌的调节因子(RANTES)、巨噬细胞炎性蛋白1α(MIP-1α)和MIP-1β的抗体不能抑制,而针对白细胞介素10、白细胞介素13、干扰素α或干扰素γ的抗体可适度降低CD8 + T细胞上清液的抗HIV活性;(iii)CD8 + T细胞上清液可抑制外周血单核细胞中的HIV-1 IIIB复制以及U1细胞中的HIV表达,而β趋化因子则不能。这些结果表明,CD8 + T细胞的HIV抑制活性是一种多因素现象,并且RANTES、MIP-1α和MIP-1β不能解释CD8 + T细胞衍生的HIV抑制因子的全部范围。

相似文献

引用本文的文献

4
The CD8 T Cell Noncytotoxic Antiviral Responses.CD8 T 细胞非细胞毒性抗病毒反应。
Microbiol Mol Biol Rev. 2021 May 12;85(2). doi: 10.1128/MMBR.00155-20. Print 2021 May 19.
5
Suppression of HIV-1 Infectivity by Human Glioma Cells.人胶质瘤细胞对HIV-1感染性的抑制作用。
AIDS Res Hum Retroviruses. 2016 May;32(5):480-8. doi: 10.1089/AID.2015.0077. Epub 2016 Jan 7.
8
Peptide and protein-based inhibitors of HIV-1 co-receptors.HIV-1 共受体的肽和蛋白质抑制剂。
Exp Biol Med (Maywood). 2013 May;238(5):442-9. doi: 10.1177/1535370213480696.

本文引用的文献

2
Chemokines and HIV replication.趋化因子与HIV复制
Nature. 1996 Aug 29;382(6594):767. doi: 10.1038/382767a0.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验